We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$6.05B
AUM Growth
+$143M
Cap. Flow
-$206M
Cap. Flow %
-3.42%
Top 10 Hldgs %
48.47%
Holding
77
New
14
Increased
23
Reduced
24
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 62.04%
2 Technology 9.78%
3 Communication Services 7.21%
4 Materials 6.27%
5 Industrials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THC icon
1
Tenet Healthcare
THC
$21.1B
$713M 11.8%
10,645,320
-3,080,000
-22% -$191M
BHC icon
2
Bausch Health
BHC
$2.34B
$479M 7.92%
16,337,549
+724,459
+5% +$21.9M
CI icon
3
Cigna
CI
$74.6B
$304M 5.04%
1,284,353
-574,514
-31% -$143M
MCK icon
4
McKesson
MCK
$101B
$283M 4.69%
1,482,070
-278,635
-16% -$53.8M
DXC icon
5
DXC Technology
DXC
$1.73B
$281M 4.65%
7,213,329
-3,369,156
-32% -$120M
PARA
6
DELISTED
Paramount Global Class B
PARA
$197M 3.27%
4,368,677
+3,868,677
+774% +$160M
COR icon
7
Cencora
COR
$61.2B
$197M 3.26%
1,719,316
-94,762
-5% -$11.2M
GPN icon
8
Global Payments
GPN
$22.8B
$174M 2.88%
926,966
+670,100
+261% +$135M
TAK icon
9
Takeda Pharmaceutical
TAK
$55.7B
$153M 2.54%
9,115,521
-6,988,701
-43% -$119M
UHS icon
10
Universal Health Services
UHS
$10.5B
$148M 2.45%
1,009,456
-149,684
-13% -$22.6M
CNC icon
11
Centene
CNC
$32.5B
$147M 2.44%
+2,020,967
New +$138M
HCA icon
12
HCA Healthcare
HCA
$89.5B
$138M 2.28%
666,935
-403,525
-38% -$82.2M
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.33T
$136M 2.25%
1,114,880
-203,800
-15% -$23.8M
CCEP icon
14
Coca-Cola Europacific Partners
CCEP
$47.9B
$136M 2.24%
2,285,833
+918,382
+67% +$53.6M
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
$121M 2%
2,297,540
+1,007,710
+78% +$54.2M
BKD icon
16
Brookdale Senior Living
BKD
$3.4B
$116M 1.92%
14,707,256
-3,341,689
-19% -$24M
META icon
17
Meta Platforms (Facebook)
META
$1.51T
$102M 1.69%
294,114
-197,741
-40% -$63.4M
BSX icon
18
Boston Scientific
BSX
$71.5B
$99.3M 1.64%
2,323,016
-874,950
-27% -$36.8M
CTVA icon
19
Corteva
CTVA
$51.3B
$98.9M 1.64%
2,230,468
+819,207
+58% +$37.8M
DD icon
20
DuPont de Nemours
DD
$19.2B
$96.3M 1.59%
990,799
+469,868
+90% +$47.2M
FMC icon
21
FMC
FMC
$1.33B
$94.4M 1.56%
872,557
+12,869
+1% +$1.49M
BAX icon
22
Baxter International
BAX
$14.2B
$94.1M 1.56%
1,169,387
-208,611
-15% -$17.5M
ESI icon
23
Element Solutions
ESI
$9.23B
$89.7M 1.48%
3,836,051
+8,783
+0.2% +$193K
QSI icon
24
Quantum-Si Incorporated
QSI
$177M
$88.1M 1.46%
7,187,091
+6,150,000
+593% +$64.4M
FISV
25
Fiserv Inc
FISV
$27.9B
$83.7M 1.39%
783,500
-93,947
-11% -$10.9M

Similar funds

Glenview Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Glenview Capital Management held 77 positions worth $6.05B, up 2.4% from $5.9B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Glenview Capital Management withdrew a net $206M in Q2 2021, closing 12 positions and reducing 24 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $135M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 68% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Glenview Capital Management opened a new position in Centene worth $147M.

  • Glenview Capital Management's largest Q2 2021 buy was Centene: 2,020,967 shares worth $147M.
  • Glenview Capital Management added most to Paramount Global Class B in Q2 2021, an estimated $160M increase.
  • Glenview Capital Management's biggest Q2 2021 reduction was Tenet Healthcare, cutting an estimated $191M.
  • Glenview Capital Management fully exited Nuance Communications, Inc. in Q2 2021, selling an estimated $135M.
  • Glenview Capital Management's ten largest holdings make up 48% of its $6.05B portfolio in Q2 2021.
  • Glenview Capital Management opened 14 new positions and closed 12 in Q2 2021.
  • Glenview Capital Management's portfolio value rose 2.4% quarter-over-quarter to $6.05B.

Based on Glenview Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.